EP03.04-02 Evaluation of Potential Therapeutic Targets with Experimental or FDA-approved Therapies in Thymic Tumor Microarrays von Ardeshir Larijani, F., Hou, T., Maniar, R., Kuhar, M., Perna, F., Loehrer, P., Mesa, H.

Volltext

P2.14A.12 Unveiling COL17A1 as a Novel Cell Surface Target in Thymic Epithelial Tumors: A Target Discovery Pipeline Approach von Ardeshir Larijani, F., Perna, F., Mesa, H., DeBrock, V.A., Alby Augustine, T., Baldrige, L.A., Liu, E., Hou, T., Cesarano, A., Gao, H., Liu, Y., Fang, F., Christopher, P., Maniar, R., Johnson, T.S., Chatterjee, D., Loehrer, P.J.

Volltext

Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency von Cheng, Aristine, Kashyap, Anuj, Salvator, Helene, Rosen, Lindsey B., Colby, Devon, Ardeshir-Larijani, Fatemeh, Loehrer, Patrick J., Ding, Li, Lugo Reyes, Saul O., Riminton, Sean, Ballman, Madison, Rocco, Joseph M., Marciano, Beatriz E., Freeman, Alexandra F., Browne, Sarah K., Hsu, Amy P., Zelazny, Adrian, Rajan, Arun, Sereti, Irini, Zerbe, Christa S., Lionakis, Michail S., Holland, Steven M.

Volltext